2025 Manufacturing Medical Relationship 
Physician's Practice
JUNE 9, 2025
of Roetzel & Andress June 9, 2025 By Austin Littrell Fact checked by Keith A. a health care attorney with Roetzel & Andress, joins the show to explore the legal risks of prescribing GLP-1 medications. Austin Littrell June 2nd 2025 Podcast Tom Price, M.D., 68: Hidden risks of prescribing GLP-1 drugs with Ericka L.
FDA Law Blog
MAY 7, 2025
Gonzalez There has been increased enforcement against medical device companies that engage in the pervasive practice of paying third party sales agents based on their volume of sales. In that decision, a medical laboratory paid Marchetti percentage-based compensation for successful referrals of Medicare patients to the laboratory.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
SEPTEMBER 20, 2021
Torrente, explained in a previous post , in-person meetings create important opportunities for building rapport, and lead to more robust dialogue and collegial relationships between the Agency and sponsors. 31, 2022; CDRP start, FY 2023; Public workshop, by July 31, 2025; Strategy document published, by April 30, 2026.
FDA Law Blog
NOVEMBER 8, 2022
By Véronique Li, Senior Medical Device Regulation Expert — At the latest MedTech conference held in Boston, MA from October 24-26, we heard from FDA officials and industry representatives on a range of topics. Below, we provide a snapshot of the three-day event: Update on the International Medical Device Regulators Forum (IMDRF).
FDA Law Blog
MAY 26, 2025
The political battle went into gear on January 28, 2025, with an Executive Order titled Protecting Children from Chemical and Surgical Mutilation. The EO and DOJ memo were followed by a May 1, 2025 announcement of a report from the U.S. FGM is defined as any procedure performed for non-medical reasons. 116(e) (emphasis added).
Expert insights. Personalized for you.
52 
Let's personalize your content